The impact of hypoxaemia on vascular function in lowlanders and high altitude indigenous populations
Michael M. Tymko,Joshua C. Tremblay,Damian M. Bailey,Daniel J. Green,Philip N. Ainslie
DOI: https://doi.org/10.1113/JP277191
2019-11-04
Journal of Physiology
Abstract:Exposure to hypoxia elicits widespread physiological responses that are critical for successful acclimatization; however, these responses may induce apparent maladaptive consequences. For example, recent studies conducted in both the laboratory and field (e.g. high‐altitude) have demonstrated that endothelial function is reduced in hypoxia. Herein, we review the several proposed mechanism(s) pertaining to the observed reduction in endothelial function in hypoxia including: a) changes in blood flow patterns (i.e. shear stress), b) increased inflammation and production of reactive oxygen species (i.e. oxidative stress), c) heightened sympathetic nervous activity, and d) increased red blood cell concentration and mass leading to elevated nitric‐oxide scavenging. Although some of these mechanism(s) have been examined in lowlanders, less in known about endothelial function in indigenous populations who have chronically adapted to environmental hypoxia for millennia (e.g. the Peruvian, Tibetan, and Ethiopian highlanders). There is some evidence indicating that healthy Tibetan and Peruvian (i.e. Andean) highlanders have preserved endothelial function at high‐altitude, but less is known about the Ethiopian highlanders. However, Andean highlanders suffering from chronic mountain sickness, which is characterized by an excessive production of red blood cells, have markedly reduced endothelial function. This review will provide a framework and mechanistic model for vascular endothelial adaptation to hypoxia in lowlanders and highlanders. Elucidating the pathways responsible for vascular adaption/maladaptation to hypoxia has potential clinical implications for disease featuring low oxygen delivery (e.g. heart failure, pulmonary disease). In addition, a greater understanding of vascular function at high‐altitude will clinically benefit the globally estimated 85 million high‐altitude residents. Figure: Overview of the conventional mechanism(s) that govern endothelial function in normoxic and hypoxic humans. This figure depicts the primary mechanism(s) governing changes in endothelial‐ dependent vascular smooth muscle vasodilation. Chronic, hypoxia (normobaric and hypobaric) results in 1) an increase in pro‐atherogenic shear stress, 2) heightened sympathetic nervous activity, 3) elevations in oxidative‐nitrosative‐inflammatory (OXINOS) stress defined by a free radical/inflammation‐mediated reduction in vascular nitric oxide bioavailability, and 4) during chronic hypoxia exposure leading to increased red blood cell concentration – increased red blood cell mediated nitric oxide scavenging. Arterial segments that are chronically exposed to low, and oscillatory shear stress preferentially develop atherosclerotic lesions (Caro et al. , 1969; Ku et al. , 1985). Increased pro‐atherogenic shear stress during hypoxia may be related to increased sympathetic nervous system outflow, which results in increased norepinephrine (i.e. NE) release sympathetic ganglia (T1‐T5, upper body vasculature; T6‐L2, lower body vasculature) onto α and β adrenergic receptors, which signal for smooth muscle vasoconstriction and vasodilation, respectively. A stimulus (e.g. shear stress) results in a release of endothelial endogenous calcium, which binds to calmodulin, and activates endothelial nitric oxide synthase (eNOS). The production of eNOS converts L‐arginine into L‐citrulline, and while doing so, releases nitric oxide. The newly produced nitric oxide is able to diffuse across the endothelial cell membrane and into the nearby smooth muscle cells. Within the smooth muscle cells, nitric oxide activates guanylate cyclase, and guanylate cyclase converts guanosine 5'‐triphosphate (GTP) into cyclic guanosine 3',5'‐monophosphate (cGMP). The cGMP upregulates cGMP dependent protein kinase G (PKG), which acts to inhibit myosin light chain kinase resulting in smooth muscle cell relaxation (Adelstein et al. , 1978; Kerrick & Hoar, 1981). Upregulated cGMP also phosphorylates voltage‐gated potassium channels resulting in potassium cellular extrusion, contributing to smooth muscle relaxation (Irvine et al. , 2003). In addition, there is some evidence that suggests that NO may independently activate voltage‐gated potassium channels (Bolotina et al. , 1994). This article is protected by copyright. All rights reserved